UBS Group
AMPE

UBS Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

UBS Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,246
Closed -$1.15K – 10482
2024
Q1 		$1.15K Buy
1,246
+1,242
+31,050% +$2.15K ﹤0.01% 8215
2023
Q4 		$8 Sell
4
-100
-96% -$259 ﹤0.01% 9134
2023
Q3 		$379 Buy
104
+101
+3,367% +$437 ﹤0.01% 8538
2023
Q2 		$16 Sell
3
-671
-100% -$3.29K ﹤0.01% 8712
2023
Q1 		$3.14K Sell
674
-134
-17% -$753 ﹤0.01% 8372
2022
Q4 		$3.72K Buy
808
+569
+238% +$3.67K ﹤0.01% 9463
2022
Q3 		$4K Buy
239
+87
+57% +$3.05K ﹤0.01% 9494
2022
Q2 		$8K Buy
152
+135
+794% +$10K ﹤0.01% 8427
2022
Q1 		$2K Sell
17
-274
-94% -$40K ﹤0.01% 9799
2021
Q4 		$50K Buy
291
+274
+1,612% +$102K ﹤0.01% 6903
2021
Q3 		$8K Buy
17
+14
+467% +$6.49K ﹤0.01% 8274
2021
Q2 		$2K Hold
3
– – ﹤0.01% 9064
2021
Q1 		$2K Hold
3
– – ﹤0.01% 8696
2020
Q4 		$2K Hold
3
– – ﹤0.01% 8156
2020
Q3 		$1K Hold
3
– – ﹤0.01% 7883
2020
Q2 		$1K Hold
3
– – ﹤0.01% 7847
2020
Q1 		$0 Sell
3
-115
-97% -$20.8K ﹤0.01% 8600
2019
Q4 		$21K Sell
118
-30
-20% -$3.88K ﹤0.01% 6857
2019
Q3 		$22K Buy
148
+145
+4,833% +$19.3K ﹤0.01% 6691
2019
Q2 		$0 Buy
+3
New +$475 ﹤0.01% 8295
2019
Q1 		– Sell
-371
Closed -$44K – 8353
2018
Q4 		$44K Buy
371
+228
+159% +$35K ﹤0.01% 6214
2018
Q3 		$22K Buy
143
+136
+1,943% +$56.8K ﹤0.01% 6758
2018
Q2 		$5K Sell
7
-5
-42% -$3.74K ﹤0.01% 7492
2018
Q1 		$13K Hold
12
– – ﹤0.01% 6733
2017
Q4 		$15K Sell
12
-7
-37% -$3.29K ﹤0.01% 6776
2017
Q3 		$3K Buy
19
+7
+58% +$1.11K ﹤0.01% 7421
2017
Q2 		$2K Sell
12
-4
-25% -$809 ﹤0.01% 7420
2017
Q1 		$4K Sell
16
-22
-58% -$5.91K ﹤0.01% 7111
2016
Q4 		$11K Sell
38
-90
-70% -$21.4K ﹤0.01% 6878
2016
Q3 		$29K Buy
128
+33
+35% +$9.25K ﹤0.01% 5977
2016
Q2 		$37K Sell
95
-26
-21% -$28.4K ﹤0.01% 5765
2016
Q1 		$82K Buy
121
+58
+92% +$39.1K ﹤0.01% 5124
2015
Q4 		$66K Sell
63
-62
-50% -$61.4K ﹤0.01% 5576
2015
Q3 		$109K Sell
125
-184
-60% -$154K ﹤0.01% 5166
2015
Q2 		$219K Buy
309
+13
+4% +$13.9K ﹤0.01% 4790
2015
Q1 		$669K Buy
296
+291
+5,820% +$496K ﹤0.01% 3912
2014
Q4 		$5K Buy
+5
New +$5.34K ﹤0.01% 9015

Other funds holding AMPE

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SWM
Sanctuary Wealth Management Pocatello, Idaho $151M AUM 17.94% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

UBS Group's AMPE Position: Q2 2024 in Review

UBS Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 1,246 shares — an estimated $1.15K sold.

UBS Group first reported a position in AMPE in Q4 2014 and held it in 37 quarters. The position peaked at $669K in Q1 2015. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.

  • UBS Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
  • UBS Group sold 1,246 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $1.15K.
  • UBS Group first reported a position in Ampio Pharmaceuticals Inc. in Q4 2014 and held it in 37 quarters.
  • UBS Group's Ampio Pharmaceuticals Inc. position peaked at $669K in Q1 2015.
  • 6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.